How does the HRSA COVID-19 Coverage Assistance Fund differ from HRSA’s COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment and Vaccine Administration for the Uninsured (HRSA COVID-19 Uninsured Program)?

The HRSA COVID-19 Coverage Assistance Fund reimburses providers for claims for COVID-19 vaccine administration provided to individuals who have health insurance, but whose health plan either does not include COVID-19 vaccination as a covered benefit or covers COVID-19 vaccine administration but with cost-sharing. In contrast, the HRSA COVID-19 Uninsured Program reimburses providers who have conducted COVID-19 testing, provided COVID-19 treatment and/or administered Food and Drug Administration (FDA) authorized COVID-19 vaccines under an Emergency Use Authorization (EUA) or FDA-licensed COVID-19 vaccines under a Biologics License Application (BLA) to individuals who did not have any health care coverage at the time the service was rendered. Both programs work toward the goal of supporting providers in increasing access to COVID-19 vaccines for individuals living in the United States. Because claims for underinsured individuals require additional coordination with insurers, however, separate portals have been established for each patient population. More information about the HRSA Uninsured Program can be found at: COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration for the Uninsured